Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 7:37 PM
Ignite Modification Date:
2025-12-25 @ 5:17 PM
NCT ID:
NCT03692403
Pre Assignment Details:
In total, 107 participants were screened. Of these, 85 were screening failures and 22 were randomized. All the randomized participants were exposed to the investigational medical product (IMP): 6 participants to Quinagolide 360 µg, 5 participants to Quinagolide 720 µg, 8 participants to Quinagolide 1080 µg and 3 participants to Placebo.
Recruitment Details:
The trial was performed in 12 investigational sites in the US between Dec 2018 and Feb 2022
Study:
NCT03692403
Study Brief:
Results Section:
NCT03692403